SMARTLOAD GAB00 (REF GAB0000175)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · SMARTLOAD SENSAR 1PC CLEAR MONO 17.5D · Class 3
All models of SMARTLOAD (52)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 05050474621732), received between Jan 25, 2024 and Jun 27, 2025 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Break1
- Scratched Material1
Patient problems
- Hyphema2
- No Clinical Signs, Symptoms or Conditions2
- Unspecified Eye / Vision Problem2
- Corneal Edema1
- Dry Eye(s)1
- Hyperemia1
- Inflammation1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 27, 2025Break; Break
IT WAS REPORTED THAT THE PRELOADED MONOFOCAL INTRAOCULAR LENS (IOL) WAS DEFECTIVE. NO ADDITIONAL INFORMATION WAS RECEIVED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22352384 ↗InjuryJul 15, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2022, THE PATIENT UNDERWENT CATARACT SURGERY IN THE RIGHT EYE (OD) AND THE MONOFOCAL INTRAOCULAR LENS (IOL) 17.5D WAS IMPLANTED. THE IOL WAS PREPARED WITH OPHTHALMIC VISCOSURGICAL DEVICE (OVD) FROM ANOTHER MANUFACTURER. DURING SURGERY AN HEMORRHAGE DUE TO CANALOPLASTY OCCURRED AND A DEEP SCLEROTOMY/SUTURE CANALOPLASTY SUPRACHOROIDAL DRAINAGE WAS PERFORMED AND AN OLOGEN IMPLANT (6 MM) WAS PLACED. THE PATIENT WAS HOSPITALIZED. ON (B)(6) 2022, THE PATIENT WAS EXAMINED AND PRESENTED AN INTRAOCULAR PRESSURE (IOP) OF 2 MMHG (-22 MMHG FROM THE BASELINE). THE UNCORRECTED DISTANCE VISUAL ACUITY (UCDVA) WAS HAND MOVEMENT. THE PATIENT PRESENTED WITH CORNEAL EDEMA, FOLDS IN DESCEMET'S AND HYPHEMA. THE PATIENT WAS ALSO DIAGNOSED WITH CONJUCTIVA CHEMOSIS AND STRESS FOLDS. ON (B)(6) 2022 THE PATIENT WAS EXAMINED AND PRESENTED AN IOP OF 5 MMHG (-19 MMHG FROM THE BASELINE). THE PATIENT ALSO PRESENTED WITH CONJUNCTIVAL HYPEREMIA/INJECTION AND HYPHEMA PERSISTED. THE PATIENT WAS DISCHARGED. THE HYPHEMA WAS REPORTED TO BE RESOLVED WITHOUT SEQUELAE ON (B)(6) 2022. THROUGH FOLLOW-UP, WE LEARNED THAT THE PATIENT IS FULLY RECOVERED. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Corneal Edema; Hyphema; Unspecified Eye / Vision Problem
MAUDE report 19746885 ↗InjuryJul 15, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2022, THE PATIENT UNDERWENT CATARACT SURGERY IN THE LEFT EYE (OS) AND THE MONOFOCAL INTRAOCULAR LENS (IOL) 17.5D WAS IMPLANTED. THE IOL WAS PREPARED WITH OPHTHALMIC VISCOSURGICAL DEVICE (OVD) FROM ANOTHER MANUFACTURER. NO SURGICAL COMPLICATIONS OCCURRED. THE FOLLOWING WAS PERFORMED A SUTURE CANALOPASTY, A SUPRACHOROIDAL DRAINAGE, OLOGEN IMPLANT (6MM). THE PATIENT WAS HOSPITALIZED. ON FEBRUARY 8, 2022 THE PATIENT WAS EXAMINED AND PRESENTED AN INTRAOCULAR PRESSURE (IOP) OF 12 MMHG (-7 MMHG FROM THE BASELINE). THE UNCORRECTED DISTANCE VISUAL ACUITY (UCDVA) WAS HAND MOVEMENT. THE PATIENT ALSO PRESENTED CONJUCTIVAL HYPEREMIA/INJECTION AND DRY EYE/SUPERFICIAL PUNCTATE KERATOPATHY/PUNCTATE EPITHELIAL EROSION/TEAR FILM INSUFFICIENCY; AND CELLS IN THE ANTERIOR CHAMBER. THE PATIENT ALSO PRESENTED AN IRIS BASE TEAR. ON (B)(6) 2022, THE PATIENT WAS DISCHARGED. THE HYPHEMA RESOLVED WITHOUT SEQUELAE. THROUGH FOLLOW-UP, WE LEARNED THAT THE PATIENT IS FULLY RECOVERED. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Dry Eye(s); Hyperemia; Hyphema; Inflammation; Unspecified Eye / Vision Problem
MAUDE report 19746879 ↗MalfunctionJan 25, 2024Scratched Material; Scratched Material
IT WAS REPORTED THAT THE PRELOADED INTRAOCULAR LENS (IOL) WAS SCRATCHED BY THE SHOOTER DURING IMPLANTATION. A NEW LENS WITH THE SAME DIOPTER WAS IMPLANTED. NO ADDITIONAL INFORMATION WAS RECEIVED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18581724 ↗
Other intraocular lens devices
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens146 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens145 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens144 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens139 reports
- TECNIS SIMPLICITY DIB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens1 recall81 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens129 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens127 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens126 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page